- Open Access
Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation
© Vrolijk et al; licensee BioMed Central Ltd. 2009
- Received: 15 December 2008
- Accepted: 11 February 2009
- Published: 11 February 2009
Two hairpin structures that are present at both the 5' and 3' end of the HIV-1 RNA genome have important functions in the viral life cycle. The TAR hairpin binds the viral Tat protein and is essential for Tat-mediated activation of transcription. The adjacent polyA hairpin encompasses the polyadenylation signal AAUAAA and is important for the regulation of polyadenylation. Specifically, this RNA structure represses polyadenylation at the 5' side, and enhancer elements on the 3' side overcome this suppression. We recently described that the replication of an HIV-1 variant that does not need TAR for transcription was severely impaired by destabilization of the TAR hairpin, even though a complete TAR deletion was acceptable.
In this study, we show that the TAR-destabilizing mutations result in reduced 3' polyadenylation of the viral transcripts due to an extension of the adjacent polyA hairpin. Thus, although the TAR hairpin is not directly involved in polyadenylation, mutations in TAR can affect this process.
The stability of the HIV-1 TAR hairpin structure is important for the proper folding of the viral RNA transcripts. This study illustrates how mutations that are designed to study the function of a specific RNA structure can change the structural presentation of other RNA domains and thus affect viral replication in an indirect way.
- Long Terminal Repeat
- Polyadenylation Site
- Viral Transcript
- Long Terminal Repeat Promoter
- AAUAAA Signal
The polyA hairpin encompasses the AAUAAA polyadenylation signal that is recognized by the cleavage polyadenylation specificity factor (CPSF), resulting in polyadenylation of the viral transcripts. Whereas TAR should exert its function in the 5' LTR promoter context, the polyadenylation signal should be recognized exclusively in the 3' LTR context. Previous studies indicated that usage of the 3' polyadenylation site is promoted by an upstream sequence element (USE) in the U3 region that is uniquely present at the 3' end of viral transcripts [18–22]. This element enhances binding of CPSF to the AAUAAA motif . The 5' polyadenylation site may also be inactive because it is positioned close to the transcription initiation site, such that polyadenylation factors have not yet gained access to the nascent transcript through the RNA polymerase II complex [24–26]. Moreover, binding of U1 snRNP to the major splice donor site that is uniquely present downstream of 5' R represses polyadenylation at the 5' polyadenylation signal [27, 28]. We previously demonstrated that the polyA hairpin masks the AAUAAA signal from recognition by CPSF and that the stability of the polyA hairpin is delicately balanced to allow 5' repression and 3' activation of polyadenylation [29–31].
We recently used the designed HIV-rtTA variant that does not need TAR for activation of transcription (Fig. 1A)[32, 33] to study additional functions of TAR in viral replication by deleting parts of this motif . We observed that virus mutants with a deletion on either the left or right side of the TAR stem (mutants A and B in Fig. 1B, respectively) are replication deficient, whereas the double mutant with a truncated TAR stem (AB) and variants with a complete TAR deletion replicate efficiently. This latter result indicates that TAR has no essential function in the viral life cycle other than to accommodate Tat-mediated activation of transcription. To understand why the single-side deletions abolished replication, we previously analyzed the effect of these mutations on the HIV-1 RNA structure . These assays with in vitro produced transcripts revealed that the 5' TAR-destabilizing mutations affect the proposed riboswitch of the leader RNA, the so called LDI-BMH equilibrium [36–38]. Whereas the wild-type transcript adopts predominantly the LDI conformation, the A and B mutants demonstrate a shift toward the alternative BMH conformation. As a result, the DIS hairpin that mediates RNA dimerization is more exposed, which affects dimerization  and packaging of the transcripts into virion particles (unpublished results). We now demonstrate an effect of 3' TAR destabilization on 3' polyadenylation of the viral transcripts in vivo. We propose that unpaired TAR nucleotides extend the polyA hairpin, thus restricting the availability of the AAUAAA signal for CPSF binding and polyadenylation.
HIV-rtTA expression is reduced by destabilization but not by truncation of the TAR hairpin
Northern blot analysis of RNA isolated from transfected C33A cells revealed that the reduced viral protein production of the A and B mutants correlated with a reduced level of unspliced (9 kb), single spliced (4 kb) and double spliced (2 kb) HIV-rtTA transcripts, whereas normal amounts were observed for the AB mutant (Fig. 2C). Several novel viral transcripts were detected for the A and B mutants, which were not observed with the TARm and AB viruses (open triangles in Fig. 2C). In addition, RNA molecules with an unexpected size were detected for all virus constructs (grey triangles). Because the viral transcripts were produced from transfected circular HIV-rtTA plasmids, these artificial RNAs may be the product of improper initiation of transcription at the 3' LTR or incomplete 3' LTR polyadenylation of correctly initiated transcripts. Both events will result in the production of odd-size transcripts that comprise vector sequences, which complicates the analysis.
Destabilization of the 3' TAR element hinders polyadenylation of viral transcripts
C33A cells were transfected with the new HIV-rtTA-SV40 constructs. After two days of culturing with dox, the original and all TAR-mutated HIV-rtTA-SV40 constructs showed no significant variation in the production of CA-p24 (Fig. 3B), which contrasts with the reduced protein production of the A and B variants that lacked the SV40 element (Fig. 2A). Analysis of the intracellular RNA by Northern blotting did indeed produce a more standard RNA pattern with only the three major RNA classes (9, 4 and 2 kb) (Fig. 3C). Within the set of 5'+3' TAR mutants an increase in the size of the A and B transcripts was apparent, whereas the size of the AB transcript was similar to that of the original (TARm) virus. This size increase corresponds with what one would expect for read-through transcription to the SV40 polyadenylation site, and was most prominent for the shorter multi-spliced transcripts. The same RNA shift was observed for 3' mutants A and B, but again not for the AB double mutant. To confirm that the longer transcripts are the result of polyadenylation at the SV40 polyadenylation site, the Northern blot membrane was stripped and hybridized with a probe that specifically detects the SV40 sequences present downstream of the 3' LTR. This analysis revealed that the extended transcripts do indeed contain this sequence (Fig. 3D).
To rule out aberrant splicing of the viral transcripts, we analyzed the splice pattern of the TAR-deleted HIV-rtTA-SV40 variants in more detail. The isolated cellular RNA was used for the synthesis of cDNA, which was PCR amplified with primer combinations that detect unspliced or spliced viral RNAs (Fig. 3E). This analysis did not reveal any difference between the original virus and modified variants indicating that the 5' and 3' mutations do not affect splicing. To confirm that the single-side TAR deletions do affect polyadenylation, the 3' end of the viral RNA was further analyzed by 3' RACE (rapid amplification of cDNA ends). The RNA was reverse transcribed using an oligo-dT primer that anneals to the polyA tail and the cDNA product was PCR amplified. For constructs with the original TARm sequence at the 3' LTR, polyadenylation will result in a PCR product of 939 bp, whereas polyadenylation at the SV40 site will result in a product of 1215 bp (Fig. 3A). For constructs with the A, B and AB deletion in the 3' TAR hairpin, these fragments will be 14, 10 and 24 bp shorter, respectively. A product corresponding to polyadenylation at the 3' LTR was observed for all viruses with a TARm or AB sequence at the 3' LTR (Fig. 3F, 939-bp product for TARm and the 5' A, B and AB mutants; 915-bp product for the 3' and 5'+3' AB variants). This demonstrates that these viruses do efficiently polyadenylate at the 3' LTR. In contrast, viruses with a single-side deletion in the 3' TAR element polyadenylated predominantly at the SV40 site, which resulted in the longer PCR product (Fig. 3F, 1201-bp product for 3' and 5'+3' A mutants; 1205-bp product for 3' and 5'+3' B variants). These results demonstrate that the single-side deletions in the 3' TAR element reduce the usage of the adjacent 3' LTR polyadenylation site. Consequently, the downstream SV40 polyadenylation site is used more frequently, resulting in transcripts that are extended by 276 nt. Quantification of the "short" and "long" forms of the double-spliced transcripts on the Northern blot (Fig. 3C) revealed that 80–90% of the viral transcripts with a complete (TARm) or truncated (AB) 3' TAR structure are processed at the natural 3' polyadenylation site, whereas only 30–40% of the transcripts with a single-side deletion in 3' TAR (A, B) are polyadenylated at this position (Fig. 3G).
We demonstrate that destabilization of the TAR hairpin in HIV-1 RNA results in reduced polyadenylation at the 3' end of the viral transcripts. Incomplete polyadenylation of the transcripts will result in read-through transcripts that contain vector or cellular genome sequences when proviral plasmids or integrated proviruses are transcribed, respectively. These improperly polyadenylated transcripts may be less stable and we did indeed observe reduced levels of viral RNA and protein (Fig. 2). The extended viral transcripts may face additional problems in the viral life cycle. For example, they may not be efficiently packaged into virions due to size restriction. Incomplete polyadenylation can thus, at least partially, explain the replication defect of the TAR-destabilized HIV-rtTA variants with a single-side deletion in the TAR stem (A and B mutants). In contrast, the double mutant with a truncated TAR hairpin (AB mutant) demonstrated efficient polyadenylation at the 3' end and viruses with this mutation replicated efficiently . Thus, the TAR hairpin itself is not needed for proper 3' LTR polyadenylation, but TAR destabilization does negatively influence this process.
We recently showed that destabilization of the 5' TAR element does affect the LDI-BMH equilibrium of the leader RNA . Whereas in vitro produced wild-type and AB-mutated leader transcripts adopted predominantly the LDI conformation, the A and B mutants demonstrated a shift toward the alternative BMH conformation. Probing of the RNA structure showed that TAR destabilization liberates TAR-nucleotides that can pair with unpaired nucleotides downstream of the polyA hairpin to extend this structure . This extension increases the thermodynamic stability (ΔG) of the polyA hairpin from -17.5 kcal/mole to -24.7 kcal/mole, as predicted by the Mfold program . Stabilization of the 5' polyA hairpin, which is part of the BMH structure, did indirectly affect the LDI/BMH equilibrium and leader-mediated RNA dimerization. Stabilization of the 3' polyA hairpin explains the reduced polyadenylation of the 3'-TAR destabilized transcripts (A and B mutants), as we previously demonstrated that such an increase in the polyA hairpin stability hinders the binding of polyadenylation factors to the AAUAAA polyadenylation signal  and decreases the efficiency of polyadenylation [29–31].
It has previously been suggested that folding of the TAR hairpin is important to appropriately space the upstream sequence element (USE) and 3' polyadenylation site in the RNA transcript . This would resemble the situation in the human T-cell leukemia virus type-I (HTLV-1), where folding of a 276-nt spacer functionally juxtaposes the AAUAAA sequence and the polyadenylation cleavage site . The AB-mutation will result in a truncated but stable stem-loop structure that will not affect the spacing between the USE and polyadenylation site. RNA structure probing studies  indicated that the A and B mutants fold an alternative, significantly less stable stem-loop structure that may effectively increase the spacer and thus contribute to the reduced polyadenylation efficiency.
Several studies suggested that the TAR hairpin has other functions in HIV-1 replication in addition to its role in transcription, such as in translation, dimerization, packaging and reverse transcription of the viral RNA [9–15, 42–44] (and references therein). Most of these studies were complicated by the fact that mutations in TAR have a dominant negative effect on viral transcription, which obscures other effects in the viral life cycle. Using the HIV-rtTA variant that does not need TAR for the activation of transcription, we recently demonstrated that complete deletion of TAR does not abolish in vitro replication, which indicates that TAR has no other essential function in HIV-1 replication . Moreover, our TAR deletion studies demonstrate that TAR destabilization is risky because it induces unwanted side effects. TAR opening triggers the formation of an extended and more stable polyA hairpin, which affects the structure and function of both the 5' leader and the 3' end of the viral RNA. These TAR mutations indirectly affect dimerization, packaging and polyadenylation of the viral transcripts, but TAR is not directly involved in these processes. Apparently, the wild-type TAR element is sufficiently stable to prevent the TAR-nucleotides from interacting with other RNA domains.
Although the TAR hairpin is not directly involved in polyadenylation of the HIV-1 RNA transcripts, destabilization of TAR does affect this process. This study demonstrates that the stability of TAR structure is important for proper folding of the adjacent polyA hairpin.
Construction of HIV-rtTA variants
Construction of the infectious HIV-rtTA molecular clone and variants with a deletion in the 5' TAR or both the 5' and 3' TAR elements were described previously [32, 34]. For the construction of the 3' TAR-mutated variants, the BamHI-BglI fragment of the constructs with both 5' and 3' deletions, which encodes the 3' half of the viral genome, was used to replace the corresponding fragment in HIV-rtTA. The SV40 polyadenylation signal was inserted downstream of the 3' LTR in these constructs as follows. We first made a pBlue-NANB cloning vector with NotI, AatII, NcoI and BamHI sites in the multiple cloning site. For this, the primers MCS-NANB-Fw (GGC CGC GAC GTC CAT GGT CTA GAT CTG GAT CCA CGT) and MCS-NANB-Rev (GGA TCC AGA TCT AGA CCA TGG ACG TCG C) were annealed and ligated into the NotI-AatII digested pBluescript fragment of pBue3'LTRext-ΔU3-rtTAF86Y A209T-2ΔtetO . The NcoI-BamHI fragment of pGL3-basic (Promega) that encodes the firefly luciferase gene and SV40 polyadenylation site was ligated into the NcoI and BamHI sites of pBlue-NANB, resulting in the pBlue-MCS-luc-SV40pA plasmid. The luciferase gene was removed by digestion with NcoI and XbaI, blunting of the sticky ends with Klenow polymerase and self-ligation of the vector to produce pBlue-MCS-SV40pA. The AatII-BglI fragment of this plasmid, which contains the SV40 polyadenylation signal, was inserted into the AatII and BglI sites downstream of the 3' LTR in the different HIV-rtTA clones.
HeLa X1/6 is a HeLa-derived cervix carcinoma cell line containing chromosomally integrated copies of the CMV-7tetO luciferase reporter construct pUHC13-3 . HeLa X1/6 and C33A (ATCC HTB31)  were grown as a monolayer in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS and minimal essential medium nonessential amino acids, penicillin (100 U/ml) and streptomycin (100 μg/ml). All cell cultures were kept at 37°C and 5% CO2.
Transient transfection and RNA isolation
C33A cells were cultured in 10-cm2 wells, grown to 60% confluency and transfected with 5 μg HIV-rtTA construct by calcium phosphate precipitation as previously described . Cells were cultured in the presence of 1 μg/ml doxycycline (dox) (Sigma D-9891) and the culture medium was changed after 16 h. The virus level in the culture medium was quantitated by CA-p24 enzyme-linked immunosorbent assay (ELISA) after two days . The cells were subsequently washed with phosphate buffered saline (PBS), briefly incubated with 0.5 ml 0.05% trypsin-EDTA (Invitrogen) till cells detached from the plate and resuspended in 1 ml 10% fetal bovine serum-containing medium to inactivate trypsin. Cells were pelleted at 2,750 × g for 5 min, washed in 1 ml PBS, centrifuged at 2,750 × g for 5 min, resuspended in 0.6 ml RLT buffer (QIAGEN) and homogenized with a QIAshredder column (QIAGEN). Total RNA was isolated with the RNeasy kit (QIAGEN) procedure, and contaminating DNA was removed with RNase-free DNase (QIAGEN) that was added during the isolation procedure as described in the RNeasy protocol.
Northern blot analysis
Gel electrophoresis of RNA was performed on a 1% agarose gel in MOPS buffer (40 mM MOPS, 10 mM sodium acetate, pH 7.0) with 7% formaldehyde at 100 Volt. The RNA was transferred overnight onto a positively charged nylon membrane (Boehringer Mannheim) by means of capillary force. RNA was attached to the membrane with a UV crosslinker (Stratagene). The 373-bp EcoRV-HinDIII fragment of HIV-rtTA encoding the U3/R region was 32P-labeled with the High Prime DNA Labeling kit (Roche Diagnostics) and used as HIV-rtTA probe. To generate the SV40 probe, the HIV-rtTA-SV40 TARm molecular clone was digested with AatII and BamHI and the 276-bp fragment was isolated and labeled as described above. Prehybridization and hybridization was done in ULTRAhyb buffer (Ambion) at 55°C for 1 and 16 h, respectively. The membrane was then washed two times at room temperature for 5 min in low-stringency buffer (2 × SSC, 0.2% SDS) and two times for 10 min at 50°C in high stringency buffer (0.1 × SSC, 0.2% SDS). Images were obtained using the PhosphorImager (Amersham Biosciences) and data analysis was performed with the ImageQuant software package. The Northern blot was stripped by boiling the membrane at 70°C in 0.1% SDS for 3 times 1 h. The stripping efficiency was controlled by scintillation counting and the blot was hybridized with the SV40 probe after prehybridization.
Splicing and polyadenylation assay
To analyze splicing and polyadenylation of the viral transcripts, the isolated RNA was reverse transcribed with ThermoScript reverse transcriptase at 50°C (Invitrogen), using the oligo(dT)25 and random hexamers primers. The cDNA product was used as template in a polymerase chain reaction (PCR) with primers 1 (GAG ACC ATC AAT GAG GAA GCT GCA GAA TGG GA) and 2 (GGC CGG CCC TTG TAG GCC GGC CAG ATC TTC CC) to detect the unspliced RNAs, with primers 3 (TCA ATA AAG CTT GCC TTG AGT GC) and 4 (CTC CGC AGA TCG TCC CAG AT) to detect the single spliced RNAs, and with primers 3 and 5 (CTA TGA TTA CTA TGG ACC ACA CA) to detect the double spliced RNAs. The polyadenylated RNAs were detected with primer 6 (CTG TGT CAG CAA GGC TTC TC) and the 3'RACE adapter primer 7 (GGC CAC GCG TCG ACT AGT ACT TTT TTT TTT TTT TTT T) that anneals to the polyA tail. The cDNA was denatured at 94°C for 5 min and amplified in 35 cycles of 1 min 95°C, 1 min 55°C, 2 min 72°C and a final extension time of 7 min at 72°C. The PCR products were visualized on a 1% agarose gel stained with ethidium bromide.
HeLa X1/6 cells were cultured in 2-cm2 wells to 60% confluency and transfected with 1 μg of the HIV-rtTA constructs and 0.5 ng pRL-CMV (Promega), in which the expression of Renilla luciferase is controlled by the CMV immediate-early enhancer promoter, to allow correction for differences in transfection efficiency. The cells were cultured with dox (1 μg/ml) and the medium was refreshed after 16 h. The culture medium was collected after 48 hours for CA-p24 measurement. The cells were washed with 1 ml PBS and subsequently lysed with passive lysis buffer (Promega). Firefly and Renilla luciferase activities were determined with the dual-luciferase assay (Promega). The rtTA level was calculated as the ratio between the firefly and Renilla luciferase activities and corrected for between session variation .
We thank Stephan Heynen for performing CA-p24 ELISA. This research was sponsored by NWO-CW (Top grant) and the Dutch AIDS Foundation (AIDS Fonds grant 2005022).
- Tan R, Brodsky A, Williamson JR, Frankel AD: RNA recognition by HIV-1 Tat and Rev. Semin Virol. 1997, 8: 186-193.View ArticleGoogle Scholar
- Molle D, Maiuri P, Boireau S, Bertrand E, Knezevich A, Marcello A, Basyuk E: A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites. Retrovirology. 2007, 4: 36-PubMed CentralView ArticlePubMedGoogle Scholar
- Richter S, Ping YH, Rana TM: TAR RNA loop: A scaffold for the assembly of a regulatory switch in HIV replication. Proc Natl Acad Sci USA. 2002, 99: 7928-7933.PubMed CentralView ArticlePubMedGoogle Scholar
- Wei P, Garber ME, Fang S-M, Fisher WH, Jones KA: A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 1998, 92: 451-462.View ArticlePubMedGoogle Scholar
- Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR: Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci USA. 1999, 96: 7791-7796.PubMed CentralView ArticlePubMedGoogle Scholar
- Parada CA, Roeder RG: Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 1996, 384: 375-378.View ArticlePubMedGoogle Scholar
- Raha T, Cheng SW, Green MR: HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol. 2005, 3: e44-PubMed CentralView ArticlePubMedGoogle Scholar
- Brady J, Kashanchi F: Tat gets the "green" light on transcription initiation. Retrovirology. 2005, 2: 69-PubMed CentralView ArticlePubMedGoogle Scholar
- Andersen ES, Contera SA, Knudsen B, Damgaard CK, Besenbacher F, Kjems J: Role of the trans-activation response element in dimerization of HIV-1 RNA. J Biol Chem. 2004, 279: 22243-22249.View ArticlePubMedGoogle Scholar
- Das AT, Klaver B, Berkhout B: The 5' and 3' TAR elements of the human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol. 1998, 72: 9217-9223.PubMed CentralPubMedGoogle Scholar
- Clever JL, Mirandar D, Parslow TG: RNA structure and packaging signals in the 5' leader region of the human immunodeficiency virus type 1 genome. J Virol. 2002, 76: 12381-12387.PubMed CentralView ArticlePubMedGoogle Scholar
- Helga-Maria C, Hammarskjold ML, Rekosh D: An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. J Virol. 1999, 73: 4127-4135.PubMed CentralPubMedGoogle Scholar
- Ooms M, Huthoff H, Russell R, Liang C, Berkhout B: A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol. 2004, 78: 10814-10819.PubMed CentralView ArticlePubMedGoogle Scholar
- Russell RS, Hu J, Bériault V, Mouland AJ, Laughrea M, Kleiman L, Wainberg MA, Liang C: Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA. J Virol. 2003, 77: 84-96.PubMed CentralView ArticlePubMedGoogle Scholar
- Berkhout B, Vastenhouw NL, Klasens BI, Huthoff H: Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription. RNA. 2001, 7: 1097-1114.PubMed CentralView ArticlePubMedGoogle Scholar
- Bennasser Y, Le SY, Yeung ML, Jeang KT: HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology. 2004, 1: 43-PubMed CentralView ArticlePubMedGoogle Scholar
- Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R, McCaffrey T, Kashanchi F: HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol. 2007, 8: 63-PubMed CentralView ArticlePubMedGoogle Scholar
- Brown PH, Tiley LS, Cullen BR: Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J Virol. 1991, 65: 3340-3343.PubMed CentralPubMedGoogle Scholar
- DeZazzo JD, Kilpatrick JE, Imperiale MJ: Involvement of long terminal repeat U3 sequences overlapping the transcription control region in human immunodeficiency virus type 1 mRNA 3' end formation. Mol Cell Biol. 1991, 11: 1624-1630.PubMed CentralView ArticlePubMedGoogle Scholar
- Gilmartin GM, Fleming ES, Oetjen J: Activation of HIV-1 pre-mRNA 3' processing in vitro requires both an upstream element and TAR. EMBO J. 1992, 11: 4419-4428.PubMed CentralPubMedGoogle Scholar
- Valsamakis A, Zeichner S, Carswell S, Alwine JC: The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. Proc Natl Acad Sci USA. 1991, 88: 2108-2112.PubMed CentralView ArticlePubMedGoogle Scholar
- Valsamakis A, Schek N, Alwine JC: Elements upstream of the AAUAAA within the human immunodeficiency virus polyadenylation signal are required for efficient polyadenylation in vitro. Mol Cell Biol. 1992, 12: 3699-3705.PubMed CentralView ArticlePubMedGoogle Scholar
- Gilmartin GM, Fleming ES, Oetjen J, Graveley BR: CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition. Genes Dev. 1995, 9: 72-83.View ArticlePubMedGoogle Scholar
- Cherrington J, Ganem D: Regulation of polyadenylation in human immunodeficiency virus (HIV): contributions of promoter proximity and upstream sequences. EMBO J. 1992, 11: 1513-1524.PubMed CentralPubMedGoogle Scholar
- Weichs an der Glon C, Monks J, Proudfoot NJ: Occlusion of the HIV poly(A) site. Genes Dev. 1991, 5: 244-253.View ArticlePubMedGoogle Scholar
- McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, Greenblatt J, Patterson SD, Wickens M, Bentley DL: The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature. 1997, 385: 357-361.View ArticlePubMedGoogle Scholar
- Ashe MP, Griffin P, James W, Proudfoot NJ: Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev. 1995, 9: 3008-3025.View ArticlePubMedGoogle Scholar
- Ashe MP, Pearson LH, Proudfoot NJ: The HIV-1 5' LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site. EMBO J. 1997, 16: 5752-5763.PubMed CentralView ArticlePubMedGoogle Scholar
- Das AT, Klaver B, Berkhout B: A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol. 1999, 73: 81-91.PubMed CentralPubMedGoogle Scholar
- Das AT, Klaver B, Klasens BIF, van Wamel JLB, Berkhout B: A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol. 1997, 71: 2346-2356.PubMed CentralPubMedGoogle Scholar
- Klasens BIF, Das AT, Berkhout B: Inhibition of polyadenylation by stable RNA secondary structure. Nucleic Acids Res. 1998, 26: 1870-1876.PubMed CentralView ArticlePubMedGoogle Scholar
- Das AT, Zhou X, Vink M, Klaver B, Verhoef K, Marzio G, Berkhout B: Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J Biol Chem. 2004, 279: 18776-18782.View ArticlePubMedGoogle Scholar
- Verhoef K, Marzio G, Hillen W, Bujard H, Berkhout B: Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol. 2001, 75: 979-987.PubMed CentralView ArticlePubMedGoogle Scholar
- Das AT, Harwig A, Vrolijk MM, Berkhout B: The TAR hairpin of human immunodeficiency virus type-1 can be deleted when not required for Tat-mediated activation of transcription. J Virol. 2007, 81: 7742-7748.PubMed CentralView ArticlePubMedGoogle Scholar
- Vrolijk MM, Ooms M, Harwig A, Das AT, Berkhout B: Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res. 2008, 36: 4352-4363.PubMed CentralView ArticlePubMedGoogle Scholar
- Huthoff H, Berkhout B: Two alternating structures for the HIV-1 leader RNA. RNA. 2001, 7: 143-157.PubMed CentralView ArticlePubMedGoogle Scholar
- Abbink TEM, Ooms M, Haasnoot PCJ, Berkhout B: The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochem. 2005, 44: 9058-9066.View ArticleGoogle Scholar
- Berkhout B, Ooms M, Beerens N, Huthoff H, Southern E, Verhoef K: In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J Biol Chem. 2002, 277: 19967-19975.View ArticlePubMedGoogle Scholar
- Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31: 3406-3415.PubMed CentralView ArticlePubMedGoogle Scholar
- Klasens BIF, Thiesen M, Virtanen A, Berkhout B: The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res. 1999, 27: 446-454.PubMed CentralView ArticlePubMedGoogle Scholar
- Bar-Shira A, Panet A, Honigman A: An RNA secondary structure juxtaposes two remote genetic signals for human T-cell leukemia virus type 1 RNA 3'-end processing. J Virol. 1991, 65: 5165-5173.PubMed CentralPubMedGoogle Scholar
- Clever JL, Eckstein DA, Parslow TG: Genetic dissociation of the encapsidation and reverse transcription functions in the 5'R region of human immunodeficiency virus type 1. J Virol. 1999, 73: 101-109.PubMed CentralPubMedGoogle Scholar
- Berkhout B: Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome. Adv Pharmacol. 2000, 48: 29-73.View ArticlePubMedGoogle Scholar
- Harrich D, Hooker CW, Parry E: The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging. J Virol. 2000, 74: 5639-5646.PubMed CentralView ArticlePubMedGoogle Scholar
- Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 1992, 89: 5547-5551.PubMed CentralView ArticlePubMedGoogle Scholar
- Auersperg N: Long-term cultivation of hypodiploid human tumor cells. J Nat Cancer Inst. 1964, 32: 135-163.PubMedGoogle Scholar
- Jeeninga RE, Jan B, Berg Van den H, Berkhout B: Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias. Retrovirology. 2006, 3: 64-PubMed CentralView ArticlePubMedGoogle Scholar
- Ruijter JM, Thygesen HH, Schoneveld OJ, Das AT, Berkhout B, Lamers WH: Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology. 2006, 3: 1-8.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.